{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:06:57Z","timestamp":1784120817549,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Associazione Italiana per la Ricerca sul Cancro (AIRC)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-0781-4","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T12:46:40Z","timestamp":1453726000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts"],"prefix":"10.1186","volume":"14","author":[{"given":"Michelandrea","family":"De Cesare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sfondrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Pennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Balsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"781_CR1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591\u2013603.","journal-title":"N Engl J Med"},{"key":"781_CR2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ctrv.2011.10.006","volume":"38","author":"P Mirarabshahii","year":"2012","unstructured":"Mirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL. Diffuse malignant peritoneal mesothelioma\u2014an update on treatment. Cancer Treat Rev. 2012;38:605\u201312.","journal-title":"Cancer Treat Rev"},{"key":"781_CR3","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49:3140\u20138.","journal-title":"Eur J Cancer"},{"key":"781_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/s10434-008-0219-1","volume":"16","author":"D Baratti","year":"2009","unstructured":"Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M. Diffuse malignant peritoneal Mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2009;16:463\u201372.","journal-title":"Ann Surg Oncol"},{"key":"781_CR5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2217\/imt.09.70","volume":"1","author":"S Adams","year":"2009","unstructured":"Adams S. Toll-like receptor agonists in cancer therapy. Immunotherapy. 2009;1:949\u201364.","journal-title":"Immunotherapy."},{"key":"781_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-065X.2008.00604.x","volume":"222","author":"MA Cheever","year":"2008","unstructured":"Cheever MA. Twelve immunotherapy drugs that could cure cancers. Immunol Rev. 2008;222:357\u201368.","journal-title":"Immunol Rev"},{"key":"781_CR7","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/eji.200939435","volume":"39","author":"JC Sun","year":"2009","unstructured":"Sun JC, Lanier LL. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol. 2009;39:2059\u201364.","journal-title":"Eur J Immunol"},{"key":"781_CR8","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.18632\/oncotarget.3761","volume":"6","author":"M Cesare De","year":"2015","unstructured":"De Cesare M, Cominetti D, Doldi V, Lopergolo A, Deraco M, Gandellini P, et al. Anti-tumor activity of selective inhibitors of XPO1\/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget. 2015;6:13119\u201332.","journal-title":"Oncotarget."},{"key":"781_CR9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Committee of the National Cancer Research Institute. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555\u201377.","journal-title":"Br J Cancer"},{"key":"781_CR10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2901","volume":"11","author":"N Baumgarth","year":"2011","unstructured":"Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11:34\u201346.","journal-title":"Nat Rev Immunol"},{"key":"781_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2567.2002.01360.x","volume":"105","author":"KS Hinkley","year":"2002","unstructured":"Hinkley KS, Chiasson RJ, Prior TK, Riggs JE. Age-dependent increase of peritoneal B-1b B cells in SCID mice. Immunology. 2002;105:196\u2013203.","journal-title":"Immunology"},{"key":"781_CR12","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.4049\/jimmunol.178.12.7779","volume":"178","author":"L Genestier","year":"2007","unstructured":"Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol. 2007;178:7779\u201386.","journal-title":"J Immunol."},{"key":"781_CR13","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.4049\/jimmunol.0900432","volume":"183","author":"CA Durand","year":"2009","unstructured":"Durand CA, Hartvigsen K, Fogelstrand L, Kim S, Iritani S, Vanhaesebroeck B, et al. Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol. 2009;183:5673\u201384.","journal-title":"J Immunol."},{"key":"781_CR14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","volume":"79","author":"J Peto","year":"1999","unstructured":"Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666\u201372.","journal-title":"Br J Cancer"},{"key":"781_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CJI.0b013e3181affaa7","volume":"33","author":"M Cesare De","year":"2010","unstructured":"De Cesare M, Sfondrini L, Campiglio M, Sommariva M, Bianchi F, Perego P, et al. Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinoma and repeatedly treated intraperitoneally with CpG-ODN. J Immunother. 2010;33:8\u201315.","journal-title":"J Immunother"},{"key":"781_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-11-25","volume":"11","author":"M Sommariva","year":"2013","unstructured":"Sommariva M, De Cesare M, Meini A, Cataldo A, Zaffaroni N, Tagliabue E, et al. High efficacy of CpG-ODN, cetuximab and cisplatin for very advanced ovarian xenograft tumors. J Transl Med. 2013;11:25.","journal-title":"J Transl Med."},{"key":"781_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","volume":"22","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231\u20137.","journal-title":"Curr Opin Immunol"},{"key":"781_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1040-8428(01)00203-7","volume":"44","author":"AH Klimp","year":"2002","unstructured":"Klimp AH, de Vries EG, Scherphof GL, Daemen T. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol. 2002;44:143\u201361.","journal-title":"Crit Rev Oncol Hematol"},{"key":"781_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.cr.7290133","volume":"12","author":"W Xu","year":"2002","unstructured":"Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res. 2002;12:311\u201320.","journal-title":"Cell Res"},{"key":"781_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.imbio.2005.05.021","volume":"210","author":"V Baron-Bodo","year":"2005","unstructured":"Baron-Bodo V, Doceur P, Lefebvre ML, Labroqu\u00e8re K, Defaye C, Cambouris C, et al. Anti-tumor properties of human-activated macrophages produced in large scale for clinical application. Immunobiology. 2005;210:267\u201377.","journal-title":"Immunobiology"},{"key":"781_CR21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","volume":"189","author":"TS Griffith","year":"1999","unstructured":"Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine. TRAIL. J Exp Med. 1999;189:1343\u201354.","journal-title":"TRAIL. J Exp Med."},{"key":"781_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2567.2008.02883.x","volume":"126","author":"AF Popi","year":"2009","unstructured":"Popi AF, Motta FL, Mortara RA, Schenkman S, Lopes JD, Mariano M. Co-ordinated expression of lymphoid and myeloid specific transcription factors during B-1b cell differentiation into mononuclear phagocytes in vitro. Immunology. 2009;126:114\u201322.","journal-title":"Immunology"},{"key":"781_CR23","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1158\/0008-5472.CAN-08-1242","volume":"68","author":"FI Staquicini","year":"2008","unstructured":"Staquicini FI, Tandle A, Libutti SK, Sun J, Zigler M, Bar-Eli M, et al. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule\/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 2008;68:8419\u201328.","journal-title":"Cancer Res"},{"key":"781_CR24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.imbio.2012.07.032","volume":"218","author":"MF Laurindo","year":"2013","unstructured":"Laurindo MF, Thies FG, Perez EC. Novaes e Brito RR, Mariano M, Popi AF. B16 melanoma cells increase B-1 cell survival, IL-10 production and radioresistance in vitro. Immunobiology. 2013;218:609\u201319.","journal-title":"Immunobiology"},{"key":"781_CR25","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1158\/0008-5472.CAN-11-1285","volume":"71","author":"M Sommariva","year":"2011","unstructured":"Sommariva M, De Cecco L, De Cesare M, Sfondrini L, M\u00e9nard S, Melani C, et al. TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res. 2011;71:6382\u201390.","journal-title":"Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0781-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:27:42Z","timestamp":1498278462000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/14\/1\/25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-0781-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"article-number":"25"}}